Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2018 Jan 10.

Published in final edited form as: Vaccine. 2014 Apr 24;32(28):3548–3554. doi: 10.1016/j.vaccine.2014.04.025

Table 1.

Number of participants in vaccinated cohort and women-only subset by AVA trial study group.

Group	Vaccinated cohort		Women only subset
	Total	Included^a	Female	Included^a^,^b
8-SQ AVA	259	252	134	80
8-IM AVA	262	256	135	71
7-IM AVA	256	250	132	76
5-IM AVA	258	249	0	0
4-IM AVA	268	260	0	0
0-SQ Placebo	127	0	64	0
0-IM Placebo	133	0	68	0
Total	1563	1267	533	227

^a

Doses 3–8.

^b

Post-menopausal, surgically sterile, and women on pharmacologic birth control were excluded.